News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Hemispherx Biopharma Avian Flu Prevention/Treatment Program Announces New Primate Results And Expands In Both Europe And Southern Hemisphere


2/14/2007 1:32:07 PM

PHILADELPHIA--(BUSINESS WIRE)--Hemispherx Biopharma, Inc. (AMEX:HEB) announced today initial results of a new primate treatment program with Viroclinics, based in the Netherlands, and directed by Professor Albert Osterhaus, a world authority in Avian influenza spread and prevention.

Read at BioSpace.com


comments powered by Disqus
 
 
Bird Flu

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES